Option Care Health, Inc. (NASDAQ: OPCH – Get Rating) Director R Carter Pate sold 1,923 shares of Option Care Health in a trade that took place on Wednesday, June 1. The stock was sold at an average price of $30.54, for a total transaction of $58,728.42. Following the sale, the administrator now owns 107,070 shares of the company, valued at $3,269,917.80. The transaction was disclosed in a filing with the SEC, which is available on the SEC’s website.
Shares of NASDAQ:OPCH traded at $0.48 during Friday’s midday session, hitting $30.23. The company had a trading volume of 609,350 shares, compared to an average volume of 809,230. The company has a fifty-day moving average price of $28.73 and a 200-day moving average price of $26.59. The company has a market capitalization of $5.44 billion, a PE ratio of 31.99, a growth price-earnings ratio of 1.40 and a beta of 1.27. The company has a debt ratio of 0.87, a current ratio of 1.59 and a quick ratio of 1.16. Option Care Health, Inc. has a one-year minimum of $18.37 and a one-year maximum of $31.08.
Option Care Health (NASDAQ:OPCH – Get Rating) last released its quarterly earnings data on Thursday, April 28. The company reported earnings per share of $0.17 for the quarter, beating the consensus estimate of $0.13 by $0.04. The company posted revenue of $915.78 million in the quarter, versus analyst estimates of $839.45 million. Option Care Health posted a net margin of 4.81% and a return on equity of 12.53%. Option Care Health’s revenue for the quarter increased 20.6% compared to the same quarter last year. During the same quarter of the previous year, the company posted an EPS of ($0.02). Research analysts expect Option Care Health, Inc. to post earnings per share of 0.89 for the current fiscal year.
Several equity research analysts have recently commented on OPCH shares. Deutsche Bank Aktiengesellschaft raised its price target on Option Care Health shares from $32.00 to $39.00 in a Friday, April 29 research report. Zacks Investment Research downgraded shares of Option Care Health from a “buy” rating to a “hold” rating in a Tuesday, May 3 research report. TheStreet downgraded shares of Option Care Health from a ‘b’ rating to a ‘c+’ rating in a Thursday, April 28 research report. Finally, Barrington Research raised its price target on Option Care Health shares from $31.00 to $33.00 in a Friday, April 29 research report. One analyst gave the stock a hold rating and five gave the company’s stock a buy rating. According to MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus price target of $31.17.
Several large investors have recently increased or reduced their stake in OPCH. Allspring Global Investments Holdings LLC purchased a new stake in Option Care Health stock in Q4 valued at $96,743,000. Marshall Wace LLP purchased a new stake in Option Care Health during Q4 for $85,991,000. Venor Capital Management LP acquired a new stake in Option Care Health during the 4th quarter at a value of $15,601,000. Norges Bank bought a new stake in Option Care Health during the 4th quarter at a value of $42,794,000. Finally, JPMorgan Chase & Co. increased its stake in Option Care Health by 172.2% in the 4th quarter. JPMorgan Chase & Co. now owns 2,032,921 shares of the company valued at $57,816,000 after purchasing an additional 1,285,972 shares in the last quarter. Institutional investors hold 98.23% of the company’s shares.
About Health Care Option (Get a rating)
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company offers anti-infective therapies; home infusion services to treat heart failure; home parenteral nutrition and enteral nutrition support services for many acute and chronic conditions, such as stroke, cancer, and gastrointestinal disease; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis and other chronic inflammatory disorders.
Get news and reviews for Option Care Health Daily – Enter your email address below to receive a concise daily summary of the latest news and analyst ratings for Option Care Health and related companies with MarketBeat.com’s FREE daily email newsletter.